At a glance
- Originator Yamanouchi
- Class
- Mechanism of Action Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Urinary incontinence
Most Recent Events
- 15 Sep 1998 Phase-II clinical trials for Urinary incontinence in Japan (Unknown route)
- 05 Feb 1998 New profile
- 05 Feb 1998 Preclinical development for Urinary incontinence in Japan (Unknown route)